Delivery Order SPE2DB22D1017-SPE2DB24FF7DB
Award Date 5/3/24
Potential Completion Date 5/6/24
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $4,020.42 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of July 16, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The firm fixed-price delivery order has a ceiling value of $4,095.00 and an ultimate completion date of June 12, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award does not have a set-aside designation, indicating it was competed openly. The...
- The federal contract award is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,044.77 and is a firm fixed-price delivery order, with an ultimate completion date of June 25, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of WEGOVY 1.7 mg/0.75 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $2,522.11, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 13, 2024 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,866.50 firm fixed price delivery order contract has a performance period through June 30, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,097.08 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 18, 2024 and was not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of WEGOVY 0.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The fixed-price delivery order has a ceiling value of $12,994.08 and a completion date of May 5, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $30,610.73 and is a Firm Fixed Price delivery order with a completion date of June 5, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial...
- This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $4,310.09 firm fixed-price delivery order was competitively awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. The contract has an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of WEGOVY 2.4 mg/0.75 ml pens. The firm-fixed-price delivery order has a ceiling value of $4,621.43 and an ultimate completion date of July 31, 2024. The contract does not have a set-aside designation. As a large indefinite delivery contract (IDC) holder with the DLA Troop Support Medical, valued up to $999,999,999, AmerisourceBergen is...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF7DBDelivery Order
This federal contract award is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and is a Delivery Order placed under an existing Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award has a ceiling value of $2,742.70 and a completion date of May 6, 2024. The contract does not have a set-aside designation.
Generated 8/2/24, 9:47 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 5/3/24 |